Medrx Co.,Ltd. Logo

Medrx Co.,Ltd.

Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.

4586 | T

Overview

Corporate Details

ISIN(s):
JP3921220004
LEI:
Country:
Japan
Address:
東かがわ市西山431番地7
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Medrx Co., Ltd., established in 2002, is a pharmaceutical company focused on drug formulation development. The company specializes in creating new dosage forms and value-added medicines, with a core technological expertise in transdermal absorption and drug delivery systems. Medrx conducts research and development to create innovative pharmaceutical candidates, which it then licenses to other companies for final clinical trials, production, and commercialization. The company's primary goal is to improve global health and patient quality of life by developing medications that offer alternatives to conventional oral administration, thereby improving patient adherence and therapeutic effectiveness.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 08:33
Interim Report
確認書
Japanese 8.9 KB
2025-08-08 08:31
Interim Report
半期報告書-第24期(2025/01/01-2025/12/31)
Japanese 425.8 KB
2025-06-13 08:31
Share Issue/Capital Change
臨時報告書
Japanese 39.1 KB
2025-03-31 08:33
Governance Information
内部統制報告書-第23期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-31 08:32
Registration Form
確認書
Japanese 8.7 KB
2025-03-31 08:32
Post-Annual General Meeting Information
臨時報告書
Japanese 25.0 KB
2025-03-31 08:32
Registration Form
訂正有価証券届出書(組込方式)
Japanese 271.6 KB
2025-03-31 08:31
Registration Form
有価証券報告書-第23期(2024/01/01-2024/12/31)
Japanese 1.4 MB
2025-03-28 07:31
Registration Form
訂正有価証券届出書(組込方式)
Japanese 268.0 KB
2025-03-25 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 409.6 KB
2024-08-09 08:01
Interim Report
確認書
Japanese 8.8 KB
2024-08-09 08:00
Interim Report
半期報告書-第23期(2024/01/01-2024/12/31)
Japanese 345.0 KB
2024-05-17 08:01
Share Issue/Capital Change
臨時報告書
Japanese 39.2 KB
2024-05-10 08:02
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-05-10 08:01
Quarterly Report
四半期報告書-第23期第1四半期(2024/01/01-2024/03/31)
Japanese 408.3 KB

Automate Your Workflow. Get a real-time feed of all Medrx Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medrx Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medrx Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DIGITAL HOLDINGS,INC. Logo
Drives business DX with data-driven advertising, CRM consulting, and AI integration.
Japan
2389
DIGITALIFT Inc. Logo
Digital marketing firm providing programmatic ad operations and strategic consulting services.
Japan
9244
D.L.S.I. Logo
HR and recruitment services for temp, fixed-term, and permanent roles across industries.
France
ALDLS
Dogwood Therapeutics, Inc. Logo
Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.
United States of America
DWTX
Investment firm leasing four Airbus A380s to Emirates for shareholder returns.
Guernsey
DNA3
Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.
Guernsey
DPA
DreamCIS INC. Logo
A CRO providing clinical research services for pharma, biotech, and medical device industries.
South Korea
223250
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea
383930
DUSKIN CO.,LTD. Logo
Franchises cleaning rentals and services for homes and businesses, and operates food chains.
Japan
4665
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan
4576

Talk to a Data Expert

Have a question? We'll get back to you promptly.